About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,616 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,616 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 441-460 of 6,616 trials

Active not recruitingA Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell LymphomaThis is a multicenter, randomized, open-label, phase 3 clinical study to evaluate the efficacy of SHR-A1912 combined with R-GemOx in relapsed refractory diffuse large B-cell…NCT06929624·Beijing, Beijing Municipality and 1 other CompletedDonor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid MalignanciesThis phase 1 trial studies the side effects and the best dose of donor CD8+ memory T-cells in treating patients with hematolymphoid malignancies.NCT01523223·Stanford, California

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

CompletedIntravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With LymphomaThis study will evaluate the safety and efficacy of intravenous AMD3100 added to a standard G-CSF mobilization regimen of patients undergoing autologous stem cell transplantation…NCT00733824·St Louis, Missouri

CompletedA Study of Obinutuzumab, Rituximab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)This study will evaluate the safety, efficacy, and pharmacokinetics of induction treatment with obinutuzumab, polatuzumab vedotin, and venetoclax in participants with relapsed or…NCT02611323·Tucson, Arizona and 22 others

UnknownHigh-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive LymphomasCentral nervous system (CNS) relapses of aggressive lymphomas are a rare but devastating complication. There is no therapy standard, conventional approaches are palliative.NCT01148173·Berlin, State of Berlin

Active not recruitingCopanlisib and Nivolumab in Treating Patients With Richter's Transformation or Transformed Indolent Non-Hodgkin LymphomaThis phase I trial studies the best dose and how well copanlisib when given together with nivolumab works in treating patients with Richter's transformation or transformed…NCT03884998·Duarte, California and 2 others

TerminatedComparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-cell Lymphoma, a Form of Non-Hodgkin's LymphomaThe purpose of this study is to evaluate whether treatment with rituximab plus sargramostim will be more effective than rituximab alone.NCT00308087·Birmingham, Alabama and 21 others

CompletedHigh-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003116·Cleveland, Ohio

RecruitingA Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)The researchers are doing this study to see if alectinib in combination with duvelisib is a safe and effective time-limited treatment for people with relapsed or refractory ALK+…NCT07001384·Basking Ridge, New Jersey and 6 others

CompletedRituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic LeukemiaRATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and kill them or carry cancer-killing substances to them.NCT00324779·Aachen and 37 others

CompletedA Combination of Rituximab and Varlilumab Immunotherapy in Patients with B-cell LymphomaA total of 40 participants will be recruited, with 20 participants in each of the following subcategories: A) High grade lymphoma (DLBCL, FL grade 3b, transformed FL) (n=20) B)…NCT03307746·Manchester and 3 others

RecruitingIbrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS LymphomaThis study is being done to answer the following question: Can the addition of a new drug to the usual treatment lower the chance of primary central nervous system lymphoma…NCT05998642·Calgary, Alberta and 7 others

CompletedThe Effect of Double Duty Interventions on Double Burden of Malnutrition Among School Adolescents in EthiopiaThe goal of this cluster randomized controlled trial is to determine the effect of double duty interventions on double burden of malnutrition, dietary diversity score, and…NCT05574842·Addis Ababa, Amhara

CompletedStudy to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle Cell LymphomaMantle Cell Lymphoma (MCL) is a form of Non-Hodgkin Lymphoma (NHL - cancer of the lymphatic system in blood) where cells from outer edge of the lymph nodes, called mantle zone…NCT04477486·Nagoya, Aichi-ken and 11 others

CompletedCognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic TrialCognitive Stimulation Therapy (CST) is an evidence-based non-pharmacological group therapy shown to benefit people with mild to moderate dementia.NCT05860127·Farmington, Connecticut and 1 other

TerminatedCellular Immunotherapy for Viral Induced Cancer - EBV Positive LymphomasTo investigate the efficacy of autologous Epstein-barr virus (EBV)-specific T cells for the treatment of EBV positive Diffuse Large B Cell Lymphoma (DLBCL), Hodgkin Lymphoma (HL)…NCT02763254·Houston, Texas

CompletedCarfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell LymphomaThis phase I/II trial studies the side effects and best dose of carfilzomib when given together with rituximab and combination chemotherapy and to see how well they work in…NCT02073097·Buffalo, New York and 2 others

UnknownClinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226)It is a multi-center, prospective, open-label, two-stage optimized design, single-arm, phase II clinical study to evaluate the efficacy and safety of GB226 for the treatment of…NCT03502629·Beijing, Beijing Municipality

CompletedGemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin LymphomaThis phase I/II trial studies the side effects and best dose of gemcitabine hydrochloride, clofarabine, and busulfan before donor stem cell transplant and to see how well it works…NCT01701986·Houston, Texas

UnknownDesign of New Personalized Therapeutic Approaches for Diffuse Large B-cell LymphomaIn Europe diffuse large B-cell lymphoma (DLBCL) is a rare disease whereas in Italy it is not.NCT03797170·Meldola, FC and 1 other

PreviousPage 23 of 331Next